At present, with the support and collaboration of Leadingpharm 's industry technical experts and research and development teams, Conlead has successfully carried out research and development work on more than 30 products, among which nearly 10 products have obtained clinical implied licenses, applied for 13 patents independently, and has successively won honors such as "Zhejiang Provincial Science and Technology-Based Small and Medium-Sized Enterprise" and "Hangzhou High-Tech Research and Development Center".
 

The award of "Hangzhou Innovative Small and Medium-Sized Enterprise" is not only an affirmation of Conlead's efforts in professional construction, innovative practice, and development potential, but also an incentive for it to accelerate the transformation of innovative achievements. In the future, Conlead will actively cooperate with influential domestic and foreign enterprises, research institutions, and scientific research institutes, accelerate the introduction and transformation of technologies and products, fill the gap in high-end pediatric drug research and development in Hangzhou, and help Hangzhou's pharmaceutical industry cluster become a world-class pharmaceutical research and development highland.
 

-END-